OFAC: Nasdaq to pay $4M over ex-subsidiary’s Iran sanctions lapses
By 
Kyle Brasseur2023-12-11T16:43:00
Nasdaq agreed to pay more than $4 million as part of a settlement with the Treasury Department’s Office of Foreign Assets Control (OFAC) addressing apparent Iran sanctions violations at the stock exchange operator’s former Armenian subsidiary.
Nasdaq OMX Armenia, the former owner and operator of the Armenian Stock Exchange (ASE), was found by OFAC to have committed 151 apparent violations of U.S. sanctions on Iran by allowing the designated Armenian subsidiary of Iran’s state-owned Bank Mellat access to its platform, according to the agency’s enforcement release published Friday.
Nasdaq voluntarily self-disclosed the matter, which OFAC deemed “non-egregious.”
Related articles
-
News BriefNasdaq unit reaches $22M settlement with CFTC over supervision failures
The Commodity Futures Trading Commission fined a Nasdaq subsidiary $22 million over allegedly misleading the public, regulators, and its own compliance staff about the details of a trader incentive program.
-
PremiumQuestions abound on foreign aid bill change to sanctions violations lookbacks
Tucked deep inside the $95 billion foreign aid bill recently passed by Congress was a provision that will allow the Office of Foreign Assets Control to look back 10 years to investigate potential violations of U.S. sanctions, rather than five years.
-
News BriefBIS rule expands export control restrictions on OFAC sanctioned entities
The Bureau of Industry and Security adopted a final rule to extend its export restrictions across more entities and individuals designated under certain sanctions programs maintained by the Office of Foreign Assets Control.
More from Regulatory Enforcement
-
News BriefFTC complaint accuses LA Fitness parent companies of blocking easy membership exits
The Federal Trade Commission filed a complaint against LA Fitness’ parent companies, citing difficulties canceling memberships, a month after a court blocked the agency’s click-to-cancel rule.
-
ArticleJudge orders CVS to pay nearly $290M for Medicare false claims
CVS’s Caremark division knowingly overcharged Medicare for prescription drugs and must pay nearly $290 million, a Pennsylvania federal judge has ordered.
-
News BriefSEC charges duo in $275 million water vending machine Ponzi scheme
The owner of a water machine vending company and a portfolio manager were allegedly behind a Ponzi-like scheme that raised more than $275 million, according to the U.S. Securities and Exchange Commission.